SEER INC (SEER)
US81578P1066 - Common Stock
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data...
Notable earnings after Thursday's close
Major earnings expected after the bell on Thursday include:Zscaler (ZS)Hewlett Packard Enterprise Company (HPE)Dell Technologies (DELL)Autodesk (ADSK)Veeva...
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new...
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new...
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new...
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new...
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
Seer technology receives recognition for excellence in the field of proteomics
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
Seer technology receives recognition for excellence in the field of proteomics...
Seer Reports Third Quarter 2023 Financial Results
Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence
Seer Reports Third Quarter 2023 Financial Results
Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence...
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services...
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for...
7 Contrarian Stocks to Buy for the High-Stakes Gambler
With limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy.
Seer to Participate in Upcoming September Investor Conferences
Seer to Participate in Upcoming September Investor Conferences
REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for...
Why Shares of Seer Are Slumping Wednesday
The company reported a net loss but improved revenue in the second quarter.
Seer GAAP EPS of -$0.37 beats by $0.04, revenue of $4M misses by $1.07M (NASDAQ:SEER)
Seer press release (SEER): Q2 GAAP EPS of -$0.37 beats by $0.04.Revenue of $4M (+11.1% Y/Y) misses by $1.07M.Expects full year 2023 revenue to be in the range of $16 million to...
Seer Reports Second Quarter 2023 Financial Results
Launched Proteograph XT Assay Kit, enabling rapid proteomics and large-scale studies
Bullish Two Hundred Day Moving Average Cross - SEER
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
SEER Crosses Above Key Moving Average Level
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new...